| Ticker Details |
ZOETIS INC.
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
|
| IPO Date: |
February 1, 2013 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$34.09B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$5.49 | 1.02%
|
| Avg Daily Range (30 D): |
$1.82 | 1.86%
|
| Avg Daily Range (90 D): |
$1.59 | 1.43%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.53M |
| Avg Daily Volume (30 D): |
6.06M |
| Avg Daily Volume (90 D): |
4.21M |
| Trade Size |
| Avg Trade Size (Sh.): |
90 |
| Avg Trade Size (Sh.) (30 D): |
75 |
| Avg Trade Size (Sh.) (90 D): |
65 |
| Institutional Trades |
| Total Institutional Trades: |
28,476 |
| Avg Institutional Trade: |
$7.95M |
| Avg Institutional Trade (30 D): |
$6.5M |
| Avg Institutional Trade (90 D): |
$8.91M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
8 |
| Market Closing Trades |
| Avg Closing Trade: |
$35.31M |
| Avg Closing Trade (30 D): |
$73.18M |
| Avg Closing Trade (90 D): |
$81.5M |
| Avg Closing Volume: |
307K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$6.04
|
$1.42
|
$1.38
|
|
Diluted EPS
|
$6.03
|
$1.42
|
$1.37
|
|
Revenue
|
$9.51B
|
$2.26B
|
$2.39B
|
|
Gross Profit
|
$6.82B
|
$1.62B
|
$1.68B
|
|
Net Income / Loss
|
$2.64B
|
$601M
|
$603M
|
|
Operating Income / Loss
|
$3.31B
|
$758M
|
$761M
|
|
Cost of Revenue
|
$2.69B
|
$641M
|
$712M
|
|
Net Cash Flow
|
$148M
|
$-509M
|
$228M
|
|
PE Ratio
|
|
|
|
|
|
|